Several therapeutic approaches aimed at inhibiting the uPA/uPAR, such as selective inhibitors of uPA activity, antagonist peptides, mAb able to prevent uPA binding to uPAR and gene therapy techniques silencing uPA/uPAR expression functions, have been shown to possess anti-tumor effects in xenograft models [97]. Here, PLAUR is linked to neoplasm.